Pages that link to "Q43537993"

The following pages link to Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis (Q43537993):

Displaying 43 items.

• Skin imaging in systemic sclerosis. (Q30372810) (← links)
• Molecular subsets in the gene expression signatures of scleroderma skin (Q33354088) (← links)
• Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis (Q33765564) (← links)
• Bone marrow transplantation in the treatment of systemic sclerosis (Q34109147) (← links)
• High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes (Q34208626) (← links)
• The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab. (Q34310749) (← links)
• Dexamethasone pulse therapy in patients of systemic sclerosis: is it a viable proposition? A study from kashmir (Q34635831) (← links)
• Concepts of functioning and health important to people with systemic sclerosis: a qualitative study in four European countries. (Q34905661) (← links)
• Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis (Q35547024) (← links)
• European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. (Q35550528) (← links)
• Non-invasive measurement of biomechanical skin properties in systemic sclerosis (Q35551389) (← links)
• Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis (Q35554342) (← links)
• Immunomodulatory therapy for SSc: will high-intensity immunosuppression with stem cell rescue improve outcome? (Q36067732) (← links)
• Preliminary study of cardiovascular manifestations and cardiac severity scale in 58 patients with systemic sclerosis in iran using the medsger scale (Q36304959) (← links)
• Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death (Q37176160) (← links)
• Treatment of systemic sclerosis: potential role for stem cell transplantation. (Q37194001) (← links)
• Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study (Q37316247) (← links)
• Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives (Q37381549) (← links)
• Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial (Q37460808) (← links)
• Stretching Reduces Skin Thickness and Improves Subcutaneous Tissue Mobility in a Murine Model of Systemic Sclerosis (Q37643874) (← links)
• Ultrasound in systemic sclerosis. A multi-target approach from joint to lung (Q38188843) (← links)
• Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease. (Q41223874) (← links)
• The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis (Q42099293) (← links)
• Iloprost therapy in systemic sclerosis (Q44573201) (← links)
• Structural Validity of the Rheumatology Attitudes Index in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study. (Q46334864) (← links)
• An Ultrasound Surface Wave Technique for Assessing Skin and Lung Diseases (Q47292923) (← links)
• Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis (Q50132702) (← links)
• Predictors of survival in 171 patients with systemic sclerosis (scleroderma) (Q50927722) (← links)
• The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement (Q51787762) (← links)
• Lung ultrasound surface wave elastography for assessing interstitial lung disease (Q57055744) (← links)
• Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis (Q61913936) (← links)
• [Systemic sclerosis - diagnosis and classification] (Q79804182) (← links)
• [Patient-centered assessment of functional health in systemic sclerosis -- where are we now?] (Q81159525) (← links)
• Combined plasmapheresis and high-dose intravenous immunoglobulin treatment in systemic sclerosis for 12 months: follow-up of immunopathological and clinical effects (Q82887723) (← links)
• What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG) (Q84583792) (← links)
• Difficulty with daily activities involving the lower extremities in people with systemic sclerosis (Q86895312) (← links)
• Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis (Q88091925) (← links)
• Hearing loss in patients with scleroderma: associations with clinical manifestations and capillaroscopy (Q88961823) (← links)
• Assessing the progression of systemic sclerosis by monitoring the tissue optic axis using PS-OCT (Q89701741) (← links)
• Ultrasound Surface Wave Elastography for Assessing Scleroderma (Q89946091) (← links)
• Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study (Q92353151) (← links)
• Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis (Q92945989) (← links)
• Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional? (Q92993709) (← links)